Welcome to the e-CCO Library!

P348: Persistent hyperCKemia during infliximab therapy in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Theodoraki E., Orfanoudaki E., Foteinogiannopoulou K., Koutroubakis I.

Created: Wednesday, 20 February 2019, 10:36 AM
P348: Top down versus step-up strategies to prevent postoperative recurrence in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Buisson, A.(1);Blanco, L.(1);Manlay, L.(1);Reymond, M.(1);Rouquette, O.(1);Dubois, A.(1);Pereira, B.(1);
Created: Friday, 11 February 2022, 3:52 PM
P349 Infliximab in inflammatory bowel disease: Is premedication necessary?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Núñez1, C. Figueroa2, L. Flores2, P. Ibáñez2, U. Kronberg3, J. Lubascher2, G. Pizarro2, R. Quera2, D. Simian2

Created: Thursday, 30 January 2020, 10:12 AM
P349: Cyclosporine has no clinically meaningful effect on pharmacokinetics (PK) of BMS-986165, an oral selective tyrosine kinase 2 (TYK2) inhibitor, in healthy subjects
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Chimalakonda*1, J. JonesIII2, R. Dockens1, J. Throup1, S. Banerjee1, I. Girgis1

Created: Friday, 22 February 2019, 9:41 AM
P349: Deep enteroscopy with a through-the-scope ballon catheter system in paediatric patients with IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Broide1,2*, T. Shalem1,3, H. Shirin1,2

Created: Thursday, 21 February 2019, 9:14 AM
P349: Faecal Calprotectin in Ulcerative Colitis - Associations with Mucosal Inflammatory Activity and Disease Extent
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Steinsbø, Ø.(1)*;Aasprong, O.G.(2);Karlsen, L.N.(1);Aabakken, L.(3);Grimstad, T.(1,4);
Created: Friday, 14 July 2023, 11:05 AM
P349: Has been withdrawn
Year: 2021
Source: ECCO'21 Virtual
Authors: Has been withdrawn
Created: Wednesday, 2 June 2021, 4:12 PM
P349: Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU).
Year: 2022
Source: ECCO'22
Authors: Bastón Rey, I.(1);Calvino Suárez, C.(1);Luque, A.M.(2);Caballol, B.(3);Soutullo, C.(4);Bravo, A.(5);Castaño, A.(6);Gros, B.(7);Hurtado, A.(8);Vázquez Rey, T.(9);Alonso Galán, H.(10);Cañete, F.(11);Castro, B.(12);Pérez Galindo, P.(13);González Muñoza, C.(14);El Hajra, I.(15);Martínez Montiel, P.(16);Alonso Abreu, I.(17);Mesonero, F.(18);González Vivo, M.(19);Peries, L.(20);Martín Arranz, E.(21);Abril, C.(22);Marín Jiménez, I.(23);Baltar, R.(24);Vicuña, M.(25);Moreno, N.(26);Brunet, E.(27);Rodríguez Lago, I.(28);Rubín de Célix, C.(29);Fajardo, I.(30);Cruz, N.(31);Rojas Feria, M.(2);Fernández Clotet, A.(3);Gimeno, M.(4);Zabana, Y.(32);Suárez Ferrer, C.(21);Barreiro de Acosta, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P349: The effects of smoking on thiopurine metabolism
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

B. Warner*1, E. Johnston1, S. Fong1, P. Blaker1, M. Arenas-Hernandez2, A. Marinaki2, J. Sanderson1

Created: Friday, 22 February 2019, 9:49 AM
P349: The therapies influencing postoperative surgical recurrence in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shinozaki M.

Created: Wednesday, 20 February 2019, 10:36 AM
P350 Perceptions of faecal microbiota transplantation in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

U.K. Chauhan1, J. Popov2, M. Kalantar2, M. Wolfe3, P. Moayyedi3, J.K. Marshall3, S. Halder3, S. Kaasalainen4

Created: Thursday, 30 January 2020, 10:12 AM
P350: Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study.
Year: 2022
Source: ECCO'22
Authors: Poullenot, F.(1);Amiot, A.(2);Nachury, M.(3);Viennot, S.(4);Altwegg, R.(5);Bouhnik, Y.(6);Abitbol, V.(7);Nancey, S.(8);Vuitton, L.(9);Peyrin-Biroulet, L.(10);Biron, A.(11);Fumery, M.(12);Picon, L.(13);Vidon, M.(14);Reenaers, C.(15);Serrero, M.(16);Savoye, G.(17);Beaugerie, L.(18);Rivière, P.(1);Laharie, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P350: Conventional biomarkers in newly diagnosed Crohn’s disease patients may predict early disease progression
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Yanai1,2*, I. Goren1,2, L. Godny1,2, S. Ben-Shachar2,3, N. Maharshak2,4, Y. Ron2,4, K. Yadgar1, K. Zonenesain1, T. Ziv-Baran5, I. Dotan1,2

Created: Thursday, 21 February 2019, 9:14 AM
P350: Endoscopic sedation in IBD patients: a propensity score-matched retrospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Levartovsky, A.(1)*;Cohen, T.(2);Klang, E.(3);Ben-Horin, S.(1);Kopylov, U.(1);
Created: Friday, 14 July 2023, 11:05 AM
P350: Induction of antiphospholipid antibodies in patients with inflammatory bowel disease treated with anti-TNFα agents
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Robles V., Herrera deGuise C., Guirola M.A., Borruel N., Casellas F.

Created: Wednesday, 20 February 2019, 10:36 AM
P350: Real-world data regarding treatment of ulcerative colitis patients with golimumab in Switzerland
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Perrig1, J-B. Rossel2, L. Biedermann1, P. Schreiner1, R. Roth1, J. Zeitz3, T. Greuter1, S. Vavricka4, N. Krupka5, P. Juillerat5, G. Rogler1, B. Misselwitz*5

Created: Friday, 22 February 2019, 9:41 AM
P350: SAFIIR: Study of Anemia Following Intravenous Iron Repletion
Year: 2021
Source: ECCO'21 Virtual
Authors: Rioux, L.C.(1);Bernard, E.J.(1);Bourgault, M.(1);Mondragon, P.(1);Rioux, V.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P350: The use of concomitant immunomodulators with adalimumab therapy in paediatric Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Benkov*1, G. Russell2, C. Samson3, S. Steiner4, E.C. King5, J. Pratt5, S. Eichner6, R.B. Colletti7, ImproveCareNow Network8

Created: Friday, 22 February 2019, 9:49 AM
P351 Spontaneous intra-abdominal abscesses in Crohn’s disease: The experience of a tertiary centre
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Pereira Guedes1, P. Sequeira2, L. Freire1, F. Castro-Poças1, A. Rocha3, M. Santos3, I. Pedroto1, P. Lago1

Created: Thursday, 30 January 2020, 10:12 AM
P351: Allogenic adipose-derived mesenchymal stem cells (darvadstrocel) in Japanese patients with complex perianal fistulas in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: WatanabeDirector of division- Assistan, K.(1);Mizushima, T.(2);Okita, Y.(3);Sugita, A.(4);Nakaya, R.(5);Shibata, M.(5);Yamaguchi , T.(5);
Created: Friday, 11 February 2022, 3:52 PM